Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
Saved in:
| Title: | Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association. |
|---|---|
| Authors: | Dennison Himmelfarb CR, Benowitz NL, Blank MD, Bhatnagar A, Chase PJ, Davis EM, Fetterman JL, Keller-Hamilton B, Ogungbe O, Page RL 2nd, Rezk-Hanna M, Robertson RM, Whitsel LP |
| Corporate Authors: | American Heart Association Advocacy Coordinating Committee |
| Source: | Circulation [Circulation] 2025 Jan 07; Vol. 151 (1), pp. e1-e21. Date of Electronic Publication: 2024 Dec 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39624904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dennison+Himmelfarb+CR%22">Dennison Himmelfarb CR</searchLink><br /><searchLink fieldCode="AU" term="%22Benowitz+NL%22">Benowitz NL</searchLink><br /><searchLink fieldCode="AU" term="%22Blank+MD%22">Blank MD</searchLink><br /><searchLink fieldCode="AU" term="%22Bhatnagar+A%22">Bhatnagar A</searchLink><br /><searchLink fieldCode="AU" term="%22Chase+PJ%22">Chase PJ</searchLink><br /><searchLink fieldCode="AU" term="%22Davis+EM%22">Davis EM</searchLink><br /><searchLink fieldCode="AU" term="%22Fetterman+JL%22">Fetterman JL</searchLink><br /><searchLink fieldCode="AU" term="%22Keller-Hamilton+B%22">Keller-Hamilton B</searchLink><br /><searchLink fieldCode="AU" term="%22Ogungbe+O%22">Ogungbe O</searchLink><br /><searchLink fieldCode="AU" term="%22Page+RL+2nd%22">Page RL 2nd</searchLink><br /><searchLink fieldCode="AU" term="%22Rezk-Hanna+M%22">Rezk-Hanna M</searchLink><br /><searchLink fieldCode="AU" term="%22Robertson+RM%22">Robertson RM</searchLink><br /><searchLink fieldCode="AU" term="%22Whitsel+LP%22">Whitsel LP</searchLink> – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22American+Heart+Association+Advocacy+Coordinating+Committee%22">American Heart Association Advocacy Coordinating Committee</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220147763%22">Circulation</searchLink> [Circulation] 2025 Jan 07; Vol. 151 (1), pp. e1-e21. <i>Date of Electronic Publication: </i>2024 Dec 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0147763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4539 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200097322%22">00097322 </searchLink><i>NLM ISO Abbreviation: </i>Circulation <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39624904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1161/CIR.0000000000001293 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1 Titles: – TitleFull: Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dennison Himmelfarb CR – PersonEntity: Name: NameFull: Benowitz NL – PersonEntity: Name: NameFull: Blank MD – PersonEntity: Name: NameFull: Bhatnagar A – PersonEntity: Name: NameFull: Chase PJ – PersonEntity: Name: NameFull: Davis EM – PersonEntity: Name: NameFull: Fetterman JL – PersonEntity: Name: NameFull: Keller-Hamilton B – PersonEntity: Name: NameFull: Ogungbe O – PersonEntity: Name: NameFull: Page RL 2nd – PersonEntity: Name: NameFull: Rezk-Hanna M – PersonEntity: Name: NameFull: Robertson RM – PersonEntity: Name: NameFull: Whitsel LP IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 01 Text: 2025 Jan 07 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1524-4539 Numbering: – Type: volume Value: 151 – Type: issue Value: 1 Titles: – TitleFull: Circulation Type: main |
| ResultId | 1 |